In refractory ovarian cancer, siRNAs were used to downregulate HIF-1 and its downstream gene VEGF. Inhibition of HIF-1 and VEGF expression reduced tumor cell proliferation rate [24]. This evidence concerns the gene HIF1A and neoplasm.